New York University School of MedicineListed a New Clinical Trial for Gut Microbiome Modulation to Enable Efficacy of Checkpoint-based Immunotherapy in Pancreatic Adenocarcinoma

Press/Media

Period27 Mar 2019

Media coverage

1

Media coverage

  • TitleNew York University School of MedicineListed a New Clinical Trial for Gut Microbiome Modulation to Enable Efficacy of Checkpoint-based Immunotherapy in Pancreatic Adenocarcinoma
    Media name/outletIndia Pharma News
    Country/TerritoryIndia
    Date27/03/19
    PersonsDeirdre Cohen
View all 1
View less